The joint company, Sirona Therapeutics Inc., is attempting to create a patch that will treat precancerous mouth lesions. According to Columbus Business First, the patches will ?directly delivers drugs aimed at stopping such lesions from developing into disfiguring and potentially fatal oral cancer.?
According to the OSU research team leader Susan Mallery, patients can see and feel potentially cancerous sores developing in the mouth. They will then be able to apply the patch with hopes that it will then dissolve the cancerous cells.
?This type of collaboration, involving multiple university partners with strong industry support, is increasingly essential to expedite the discovery, development and delivery of more targeted cancer therapies. There is no routine cancer, and today, it takes the collective minds across disciplines, institutions and industry to move the field forward,? said Michael Caligiuri, MD, director of The Ohio State University Comprehensive Cancer Center. ?Ultimately, these collaborations can be the catalyst for new, more effective cancer treatments, leading to better outcomes, faster responses, fewer side effects and more hope for cancer patients everywhere,?
The patch reportedly avoids toxicity issues and is an ?excellent chemopreventive compound? that can be used on precancerous cells.
The Oral Cancer Foundation says that 43,250 new cases of oral cancer will be diagnosed this year. Over 8,000 people will succumb to the disease and of the over 43,000 individuals diagnosed, 57% will still be alive in 5 years.